Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Animal-used compound preparation for treating virosis of livestock and fowl and preparation method thereof

A technology for viral venereal diseases and compound preparations, which is applied in the directions of antiviral agents, medical preparations containing active ingredients, and pill delivery. Use safe effects

Inactive Publication Date: 2007-08-08
江西百思技术咨询有限公司
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patented medicine has several technical benefits that make it better than existing treatments such as vaccines or antibiotics against bacterial disease on farms worldwide. These medications can be used without causing harm if they don't work well with other animals. They have been proven scientifically by researchers at different levels from animal health experts over many years ago.

Problems solved by technology

This patented technical problem addressed by this patents relates to developing an improved medicinal formula for use against animal or bird infectious agents without being limited due to their lack of effective therapeutic options available at current medical practices.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0010] Embodiment one (injection)

[0011] Astragalus polysaccharide 50g Ribavirin 25g

[0012] The preparation method of the present invention: take prescription amount of astragalus polysaccharide and ribavirin respectively, add appropriate amount of solvent for injection, stir to dissolve, then add prescription amount of antioxidant and metal complexing agent, stir to dissolve, add additional solvent for injection To the full amount, adjust the pH value, filter, pot, sterilize at 100°C for 30 minutes, cool, light check, print, pack, and you are ready.

Embodiment 2

[0013] Embodiment two (tablet)

[0014] Astragalus polysaccharide 50g Ribavirin 25g

[0015] The preparation method of the present invention: first pulverize ribavirin, pass through a 100-mesh sieve, and set aside, take the prescription amount of adhesive auxiliary materials, add an appropriate amount of purified water to prepare the adhesive, set aside, weigh the prescription amount of astragalus polysaccharide, Bavirin fine powder, filler and disintegrating agent are uniformly mixed by the method of equal increasing, adding binder to make soft material, granulating, drying, granulating, adding prescription amount of lubricant, mixing, pressing Tablets, inspected, packaged, ready to be obtained.

Embodiment 3

[0016] Embodiment three (tablet)

[0017] Astragalus polysaccharide 50g Morpholine hydrochloride 50g

[0018] The preparation method of the present invention: first pulverize morpholine guanidine hydrochloride, pass through a 100-mesh sieve, set aside, take the prescription amount of adhesive auxiliary materials, add an appropriate amount of purified water to prepare the adhesive, set aside, take the prescribed amount of astragalus polysaccharide, hydrochloric acid Morpholine guanidine fine powder, filler and disintegrating agent are uniformly mixed by the method of equal increase, adding binder to make soft material, granulating, drying, sizing, adding prescription amount of lubricant, mixing, pressing Tablets, inspected, packaged, ready to be obtained.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method for preparing animal composite agent which can be used to treat virus disease of animal. The inventive agent comprises main drug and findings, wherein, the main drug is formed by 10-100 deals of astragalus root polysaccharide and one of following drugs as 5-50 deals of ribawellin, 10-100 deals of moroxydine, and 5-50 deals of amantadine hydrochloride; and the findings are prepared from one or two of following materials as 1-2 deals of anti-oxidant, 0.1-0.2 deals of metal complex builder, 740-950 deals of injection dissolvent, 740-950 deals of stuff, 50-200 deals of disintegration agent, 10-50 deals of adhesive and 3-60 deals of lubricant. The invention develops a novel animal agent for treating the virus disease and improving immunity, while it all uses relative high-effect drugs, with stable agent, long storage time, controllable quality and accurate agent consumption.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Owner 江西百思技术咨询有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com